search
Back to results

Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope

Primary Purpose

Asthma

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
Electronic Stethoscope
Standard treatment according to GINA(2019)
Sponsored by
Shanghai Children's Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Asthma focused on measuring Pediatric, Asthma Control, Electronic Stethoscope

Eligibility Criteria

3 Years - 6 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" in the respiratory clinic of Shanghai Children's Medical Center from January 2023 to January 2025 Out-patient, female or male, 3 years old≤ age < 6 years old long-term maintenance therapy with inhaled glucocorticoids or concomitant leukotriene receptor antagonists Equipped with a household atomizer or spacer, it can afford the inhalation therapy of short-acting β2 receptor agonists (SABA) at home The subjects or subjects' caregiver must have a smart phone with Android or Harmony system at their disposal The guardian agrees to participate in the study and signs the informed consent form Exclusion Criteria: Acute exacerbation of asthma 30 days before enrollment (receive short-term prednisone treatment, emergency department visit or hospitalization due to acute asthma attacks) Other chronic lung diseases, cardiovascular diseases, blood system diseases, immunodeficiency diseases, neurological diseases, genetic or chromosomal abnormalities and other underlying diseases Patients or their caregivers can't complete the collection of breath sound

Sites / Locations

  • Shanghai Children's Medical CenterRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

electronic stethoscope group

control group

Arm Description

During the study, subjects who diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" will be assigned to the control group and the electronic stethoscope group, and receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children". The patient's caregiver will be instructed to use an electronic stethoscope to coordinate treatment and complete follow-up.

During the study, subjects who diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" will be assigned to the control group and the electronic stethoscope group, and receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children".

Outcomes

Primary Outcome Measures

visits of asthma-related unplanned emergency department
Subjects will fill out a questionnaire to provide the number of unscheduled emergency department visits related to asthma (except for routine asthma follow-up visits every 3 months).

Secondary Outcome Measures

asthma control
The patients' caregiver will be prompted to fill out an asthma control questionnaire every month. This questionnaire contains questions regarding renewal of prescription, control status and asthma attack.
adherence to asthma treatment
Patients' adherence will be assessed by investigator through questionnaire.

Full Information

First Posted
December 13, 2022
Last Updated
February 2, 2023
Sponsor
Shanghai Children's Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05659225
Brief Title
Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope
Official Title
Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 1, 2023 (Actual)
Primary Completion Date
December 31, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Shanghai Children's Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to retrofit the existing electronic stethoscope, improve the quality and efficiency of signal acquisition and the intelligent degree of information processing, decrease the manual action of electronic stethoscopes implemented by parents of asthma children, simplify the process of data transfer and the user's operational cost using signal processing, artificial intelligence technology, thus decreasing the feedback cycle between patients and clinicians. Eventually, we will construct an intelligent monitoring system based on the modified electronic stethoscope and explore the interactive remote management approaches on children's asthma at the same time, thus achieving revolutionized remote management of asthma.
Detailed Description
(1) The design of hardware and software of the intelligent electronic stethoscope This project will optimize and develop the software and hardware equipment of electronic stethoscope according to the shortcomings of existing electronic stethoscopes. Get high-quality breath sound data through integrated ECG sensor and algorithms for denoising and the separation of heart sound and lung sound Develop algorithms and corresponding frameworks for visualization of breath sounds and mining of key information Develop algorithms for automatic recognition of abnormal breath sounds Transfer breath sound data efficiently and reliably based on the encoding-decoding architecture Optimize the breath sound data transmission process Construct the remote diagnosis and treatment methods and monitoring system for childhood asthma preliminary (2) The effect of telemedicine system and intelligent monitoring system based on intelligent stethoscope on children with asthma Subjects diagnosed as pediatric asthma at Shanghai Children's Medical Center will be consecutively screened and eligible patients will be recruited. For each enrolled patient, basic information as well as baseline medical condition will be collected by the investigators. The subject will be randomly assigned to the control group and the electronic stethoscope group. The patient's caregiver who was assigned to the electronic stethoscope group will be instructed to install the electronic stethoscope developed by our team and its accessories, then they will be trained by investigators on how to use the electronic stethoscope. During the study, patients will receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children". If patients develop upper respiratory tract symptoms without fever, the investigator will give corresponding guidance to the control group and the electronic stethoscope group. If fever develops, it is recommended that patients directly go to the emergency department. All patients' caregiver will be prompted to finish the test for respiratory and asthma control in kids (TRACK) every month. Patient's caregiver assigned to the electronic stethoscope group will also need to complete the collection, data upload and sharing of patient's breath sounds at least once a month to confirm that the electronic stethoscope is worked correctly. After enrollment, patients will be requested to visit Shanghai Children's Medical Center at month 3, 6, 9, 12. During each onsite visit, subjects will receive lung function (≥4 years) and FENO tests and fill out the questionnaire regarding the number of asthma-related outpatient emergency department visits, asthma-related hospitalizations, SABA and systemic glucocorticoid use, missed work and school misses, and asthma-related medical expenses in the past 3 months. At 6- and 12-month's visit, pediatric asthma caregiver's quality of Life questionnaire (PACQLQ) needs to be completed at the same time.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Pediatric, Asthma Control, Electronic Stethoscope

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
208 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
electronic stethoscope group
Arm Type
Other
Arm Description
During the study, subjects who diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" will be assigned to the control group and the electronic stethoscope group, and receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children". The patient's caregiver will be instructed to use an electronic stethoscope to coordinate treatment and complete follow-up.
Arm Title
control group
Arm Type
Other
Arm Description
During the study, subjects who diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" will be assigned to the control group and the electronic stethoscope group, and receive 12 months standard treatment, prescribed by the investigators according to "Guideline for the diagnosis and optimal management of asthma in children".
Intervention Type
Device
Intervention Name(s)
Electronic Stethoscope
Other Intervention Name(s)
study-specified asthma device program
Intervention Description
Subjects diagnosed as pediatric asthma at Shanghai Children's Medical Center will be consecutively screened and eligible patients will be recruited (enrolment visit, V1). The subject will be assigned to the control group and the electronic stethoscope group and complete their future onsite visits (V2-V5) at Shanghai Children's Medical Center. The patient's caregiver who was assigned to the electronic stethoscope group will be instructed to install the electronic stethoscope developed by our team and its accessories, then they will be trained by investigators on how to use the electronic stethoscope.
Intervention Type
Other
Intervention Name(s)
Standard treatment according to GINA(2019)
Intervention Description
Subjects diagnosed as pediatric asthma at Shanghai Children's Medical Center will be consecutively screened and eligible patients will be recruited (enrolment visit, V1). The subject will be assigned to the control group and the electronic stethoscope group and complete their future onsite visits (V2-V5) at Shanghai Children's Medical Center. The patient's caregiver who was assigned to the control group will receieve standard treatment according to GINA(2019).
Primary Outcome Measure Information:
Title
visits of asthma-related unplanned emergency department
Description
Subjects will fill out a questionnaire to provide the number of unscheduled emergency department visits related to asthma (except for routine asthma follow-up visits every 3 months).
Time Frame
1 year
Secondary Outcome Measure Information:
Title
asthma control
Description
The patients' caregiver will be prompted to fill out an asthma control questionnaire every month. This questionnaire contains questions regarding renewal of prescription, control status and asthma attack.
Time Frame
1 year
Title
adherence to asthma treatment
Description
Patients' adherence will be assessed by investigator through questionnaire.
Time Frame
1 year
Other Pre-specified Outcome Measures:
Title
SABA use
Description
Number of days and total amount of SABA use will be collected by investigator through questionnaire.
Time Frame
1 year
Title
systemic corticosteroid use
Description
Days of systemic corticosteroid use will be counted by investigator through questionnaire.
Time Frame
1 year
Title
lung function
Description
Subjects (equal or older than 4 years) will receive PEF (Peak expiratory flow, L/min) tests for evaluation of lung function.
Time Frame
1 year
Title
FENO tests
Description
Subjects will receive FENO (Fractional exhaled nitric oxide, parts per billion, ppb) tests for evaluation of lung inflammation level.
Time Frame
1 year
Title
Asthma-related medical expenses
Description
Asthma-related medical expenses will be counted by investigator through questionnaire.
Time Frame
1 year
Title
Asthma-related hospitalizations
Description
Number of asthma-related hospitalizations will be collected by investigator through questionnaire.
Time Frame
1 year
Title
Missed school and parents missed work
Description
Number of missed school and parents missed work will be collected by investigator through questionnaire.
Time Frame
1 year
Title
Patients' and caregivers' quality of life
Description
Patients' and caregivers' quality of life will be evaluated by investigator through questionnaire.
Time Frame
1 year
Title
Caregivers' satisfaction degree with electronic stethoscopes
Description
Caregivers' satisfaction degree with electronic stethoscopes will be assessed by investigators through questionnaire.
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
3 Years
Maximum Age & Unit of Time
6 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosed as asthma according to "Guideline for the diagnosis and optimal management of asthma in children" in the respiratory clinic of Shanghai Children's Medical Center from January 2023 to January 2025 Out-patient, female or male, 3 years old≤ age < 6 years old long-term maintenance therapy with inhaled glucocorticoids or concomitant leukotriene receptor antagonists Equipped with a household atomizer or spacer, it can afford the inhalation therapy of short-acting β2 receptor agonists (SABA) at home The subjects or subjects' caregiver must have a smart phone with Android or Harmony system at their disposal The guardian agrees to participate in the study and signs the informed consent form Exclusion Criteria: Acute exacerbation of asthma 30 days before enrollment (receive short-term prednisone treatment, emergency department visit or hospitalization due to acute asthma attacks) Other chronic lung diseases, cardiovascular diseases, blood system diseases, immunodeficiency diseases, neurological diseases, genetic or chromosomal abnormalities and other underlying diseases Patients or their caregivers can't complete the collection of breath sound
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Yong Yin, PhD
Phone
8618930830705
Email
yinyong9999@163.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Yong Yin, PhD
Organizational Affiliation
Shanghai Children's Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Shanghai Children's Medical Center
City
Shanghai
State/Province
Shanghai
ZIP/Postal Code
200127
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yong Yin, PhD
Phone
8618930830705
Email
yinyong9999@163.com

12. IPD Sharing Statement

Learn more about this trial

Telemedicine System and Intelligent Monitoring System Construction of Pediatric Asthma Based on the Electronic Stethoscope

We'll reach out to this number within 24 hrs